BCAS3
Basic information
Region (hg38): 17:60677453-61392838
Links
Phenotypes
GenCC
Source:
- Hengel-Maroofian-Schols syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hengel-Maroofian-Schols syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 34022130 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hengel-Maroofian-Schols syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BCAS3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 61 | 63 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 1 | 61 | 2 | 2 |
Variants in BCAS3
This is a list of pathogenic ClinVar variants found in the BCAS3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-60679519-T-C | Inborn genetic diseases | Uncertain significance (Aug 15, 2024) | ||
17-60679530-C-T | Global developmental delay • Hengel-Maroofian-Schols syndrome | Pathogenic/Likely pathogenic (Sep 12, 2023) | ||
17-60683995-A-G | Inborn genetic diseases | Uncertain significance (Jan 24, 2024) | ||
17-60689716-A-G | Inborn genetic diseases | Uncertain significance (May 23, 2024) | ||
17-60689725-A-G | Inborn genetic diseases | Uncertain significance (Mar 08, 2024) | ||
17-60689735-T-C | Inborn genetic diseases | Uncertain significance (Dec 14, 2021) | ||
17-60747213-C-T | Global developmental delay | Likely pathogenic (Jan 12, 2021) | ||
17-60747232-G-A | Inborn genetic diseases | Uncertain significance (Nov 25, 2024) | ||
17-60747234-C-T | Inborn genetic diseases | Uncertain significance (Dec 19, 2023) | ||
17-60747235-A-C | Inborn genetic diseases | Uncertain significance (Jun 24, 2022) | ||
17-60747250-C-T | Inborn genetic diseases | Uncertain significance (May 28, 2024) | ||
17-60747262-T-A | Hengel-Maroofian-Schols syndrome | Likely pathogenic (-) | ||
17-60808006-G-C | Inborn genetic diseases | Uncertain significance (Dec 22, 2023) | ||
17-60868576-C-T | Inborn genetic diseases | Likely benign (Oct 01, 2024) | ||
17-60868628-AT-A | Global developmental delay | Likely pathogenic (Jan 12, 2021) | ||
17-60868675-C-A | Global developmental delay | Likely pathogenic (Jan 12, 2021) | ||
17-60868682-C-T | Inborn genetic diseases | Uncertain significance (May 18, 2022) | ||
17-60874669-G-T | Inborn genetic diseases | Uncertain significance (Dec 13, 2022) | ||
17-60889701-A-G | Inborn genetic diseases | Uncertain significance (Nov 11, 2024) | ||
17-60889730-A-G | Inborn genetic diseases | Likely benign (Jul 11, 2023) | ||
17-60889745-C-T | Inborn genetic diseases | Uncertain significance (Aug 30, 2021) | ||
17-60889759-T-G | Hengel-Maroofian-Schols syndrome • Global developmental delay | Pathogenic/Likely pathogenic (Sep 12, 2023) | ||
17-60902641-C-T | Inborn genetic diseases | Uncertain significance (Dec 10, 2024) | ||
17-60902642-G-A | Inborn genetic diseases | Uncertain significance (Dec 02, 2022) | ||
17-60910599-G-A | Inborn genetic diseases | Uncertain significance (Mar 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BCAS3 | protein_coding | protein_coding | ENST00000390652 | 24 | 715386 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000138 | 1.00 | 124771 | 0 | 37 | 124808 | 0.000148 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.60 | 375 | 546 | 0.687 | 0.0000307 | 6050 |
Missense in Polyphen | 153 | 224.41 | 0.68178 | 2416 | ||
Synonymous | 0.226 | 192 | 196 | 0.979 | 0.0000114 | 1840 |
Loss of Function | 4.80 | 18 | 57.2 | 0.315 | 0.00000358 | 574 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000449 | 0.000449 |
Ashkenazi Jewish | 0.000200 | 0.000199 |
East Asian | 0.000167 | 0.000167 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000107 | 0.000106 |
Middle Eastern | 0.000167 | 0.000167 |
South Asian | 0.0000988 | 0.0000980 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in angiogenesis. Participates in the regulation of cell polarity and directional endothelial cell migration by mediating both the activation and recruitment of CDC42 and the reorganization of the actin cytoskeleton at the cell leading edge. Promotes filipodia formation (By similarity). Functions synergistically with PELP1 as a transcriptional coactivator of estrogen receptor-responsive genes. Stimulates histone acetyltransferase activity. Binds to chromatin. {ECO:0000250|UniProtKB:Q8CCN5, ECO:0000269|PubMed:17505058}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving BCAS3 has been found in some breast carcinoma cell lines. Translocation t(17;20)(q23;q13) with BCAS4.;
- Pathway
- Ectoderm Differentiation
(Consensus)
Intolerance Scores
- loftool
- 0.479
- rvis_EVS
- -0.75
- rvis_percentile_EVS
- 13.67
Haploinsufficiency Scores
- pHI
- 0.637
- hipred
- Y
- hipred_score
- 0.682
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.948
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bcas3
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype;
Gene ontology
- Biological process
- angiogenesis;Golgi organization;positive regulation of endothelial cell migration;microtubule organizing center organization;negative regulation of GTPase activity;tube formation;response to starvation;positive regulation of catalytic activity;positive regulation of GTPase activity;positive regulation of transcription by RNA polymerase II;positive regulation of filopodium assembly;negative regulation of focal adhesion assembly;cellular response to estrogen stimulus;positive regulation of intracellular protein transport;activation of GTPase activity;regulation of establishment of cell polarity;positive regulation of actin cytoskeleton reorganization
- Cellular component
- nucleus;nucleolus;cytoplasm;cytoplasmic microtubule;cell leading edge;transcriptionally active chromatin;intermediate filament cytoskeleton;cell periphery
- Molecular function
- chromatin binding;protein binding;transcription factor binding;acetyltransferase activator activity;histone acetyltransferase binding;nuclear hormone receptor binding;histone binding;beta-tubulin binding